Lör 27 nov / År 39 / Nr 4 2021

Meet the specialists in Osseointegration

The discovery of the medical and technical phenomenon osseointegration has made Gothenburg what it is today when it comes to implant technology and development. Integrum has refined the osseointegration method for almost 30 years and is continuously improving quality of life for people around the world using the next generation implant system- The OPRATM Implant System.

Titanium implants would not be used routinely and globally today if not for the pioneering work of Swedish physician Per-Ingvar Brånemark. In the 1960s, he was the first to observe that the human body would not only tolerate titanium, but even integrate it into living tissue in a process he called osseointegration. This insight has revolutionised the fields of dental, maxillofacial and orthopaedic rehabilitation.

Improving intuitive control and sensory
Based on Per-Ingvar Brånemark’s original scientific findings, innovative bone-anchored restorative solutions have improved the quality of life for millions of people around the world for decades. Integrum takes the technology and very idea of osseointegration further by developing the e-OPRATM Implant system, a system so advanced it can even restore touch in prostheses. This is as close to a real life feeling as possible with today’s technology.
”Modern prostheses are now capable of mimicking fine movements and grips, but the level of intuitive control and sensory feedback is still limited. This is one of the biggest challenges for Integrum, and remains core focus for our future development”, says Rickard Brånemark, Founder of Integrum.
The e-OPRATM Implant System allows simultaneous connection to bone, muscles, and nerves for long-term home use. This technology, in addition to providing intuitive and natural control, also provides sensory feedback by stimulating the severed nerves. But Integrum wants to take it further, aiming to regenerate life-like sensory and control as close to nature as possible.

The only FDA-approved supplier
The OPRATM Implant System is the pioneering technology in bone-anchored prostheses and the only FDA-approved (Humanitarian Device Exemption) bone-anchored system available in the United States.
“The United States is the key market for Integrum and being the only FDA-approved supplier gives us a clear advantage when we take our technology to the next level. Our vision at Integrum is to be a global player in orthopaedics, with special focus on large and emerging markets. With a complete FDA-approval we are free to commercialise our products without limitations, and this is what we are striving for now in the near future”, says Maria Elena Lopez, Integrum CEO.
Integrum headquarters are to remain in Mölndal in the Gothenburg region, with supporting development offices in USA.